- Home
- PRLD vs BRID Comparison
PRLD vs BRID Comparison
Compare PRLD & BRID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- BRID
- Stock Information
- Founded
- PRLD 2016
- BRID 1932
- Country
- PRLD United States
- BRID United States
- Employees
- PRLD N/A
- BRID N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- BRID Specialty Foods
- Sector
- PRLD Health Care
- BRID Consumer Staples
- Exchange
- PRLD Nasdaq
- BRID Nasdaq
- Market Cap
- PRLD 69.1M
- BRID 72.8M
- IPO Year
- PRLD 2020
- BRID N/A
- Fundamental
- Price
- PRLD $1.36
- BRID $7.55
- Analyst Decision
- PRLD Strong Buy
- BRID
- Analyst Count
- PRLD 3
- BRID 0
- Target Price
- PRLD $4.00
- BRID N/A
- AVG Volume (30 Days)
- PRLD 3.2M
- BRID 3.7K
- Earning Date
- PRLD 10-31-2025
- BRID 08-22-2025
- Dividend Yield
- PRLD N/A
- BRID N/A
- EPS Growth
- PRLD N/A
- BRID N/A
- EPS
- PRLD N/A
- BRID N/A
- Revenue
- PRLD $7,000,000.00
- BRID $227,364,000.00
- Revenue This Year
- PRLD N/A
- BRID N/A
- Revenue Next Year
- PRLD N/A
- BRID N/A
- P/E Ratio
- PRLD N/A
- BRID N/A
- Revenue Growth
- PRLD N/A
- BRID N/A
- 52 Week Low
- PRLD $0.61
- BRID $7.28
- 52 Week High
- PRLD $4.22
- BRID $10.83
- Technical
- Relative Strength Index (RSI)
- PRLD 47.51
- BRID 42.99
- Support Level
- PRLD $1.43
- BRID $7.55
- Resistance Level
- PRLD $4.19
- BRID $8.02
- Average True Range (ATR)
- PRLD 0.40
- BRID 0.25
- MACD
- PRLD -0.01
- BRID -0.05
- Stochastic Oscillator
- PRLD 6.44
- BRID 4.37
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About BRID Bridgford Foods Corporation
Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.